Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
01/27/2005 | WO2005007805A2 ANTISENSE ANTIVIRAL AGENT AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
01/27/2005 | WO2005007663A2 Fluorogenic enzyme substrates and uses thereof |
01/27/2005 | WO2005007121A2 Mutant interleukin-2(il-2) polypeptides |
01/27/2005 | WO2005007119A2 Assays for protease enzyme activity |
01/27/2005 | WO2005006958A2 Modulation of ceacam1 expression |
01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
01/27/2005 | WO2004052300A3 Modulation of alpha-methylacyl-coa racemase expression |
01/27/2005 | WO2003054211A3 Receptors for hypersensitive response elicitors and uses thereof |
01/27/2005 | US20050020827 Thermolabile hydroxyl protecting groups and methods of use |
01/27/2005 | US20050020826 Mixing a pyrimidine derivative having a specific base sequence with a sample suspected of containing a target nucleic acid having a base sequence that is complementary or complementary to the compound's base sequence to form a complex, |
01/27/2005 | US20050020526 Oligodeoxynucleotide intervention for prevention and treatment of sepsis |
01/27/2005 | US20050020523 Modified antisense nucleotides complementary to a section of the human haras gene |
01/27/2005 | US20050020522 Induce mitrosis and smooth muscle proliferation; administering to cell or tissue a polynucleotide which codes endothelial growth factor |
01/27/2005 | US20050020521 In vivo gene silencing by chemically modified and stable siRNA |
01/27/2005 | US20050019916 oligonucleotides used for detection and analyzing analytes in solution |
01/27/2005 | US20050019915 Oligonucleotides for use in controlling expression of gene coding polypeptide associated with catalyzing the dismutation of superoxide to hydrogen peroxide; antiproliferative agents; antitumor agents; gene expression inhibition |
01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
01/27/2005 | US20050019863 Culture product of Escherichia; transformation with plasmids using Dna sequences |
01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
01/27/2005 | US20050019800 Multicompartment apparatus which utilizes fluorescence from conductive polymers to determine sequence of preferential nucleotide sequences |
01/27/2005 | US20050019779 Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization |
01/27/2005 | US20050019777 Gene therapy; multi-tissue Northern Blotting; expression vectors; host cells; drug screening; osteoarthritis |
01/27/2005 | US20050019771 Novel germinal center kinase proteins, compositions, and methods of use |
01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
01/27/2005 | US20050019752 Novel chimeric rev, tat, and nef antigens |
01/27/2005 | US20050019751 Contacting human scavenger receptor class B type I with polypeptide and measuring ability of test compound to inhibit binding; used in treatment and prophylaxis |
01/27/2005 | US20050019346 Nucleic acids and regulatory sequences; gene expression; antitumor agents |
01/27/2005 | US20050019343 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
01/27/2005 | US20050019330 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta |
01/27/2005 | US20050019251 Administering isotope labeled water to tissue; measurement; calibration |
01/27/2005 | CA2536376A1 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
01/27/2005 | CA2533309A1 Assays for protease enzyme activity |
01/27/2005 | CA2532186A1 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
01/27/2005 | CA2531709A1 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
01/27/2005 | CA2531571A1 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
01/27/2005 | CA2531560A1 Hairpin-labeled probes and methods of use |
01/27/2005 | CA2531069A1 Inhibition of syk kinase expression |
01/27/2005 | CA2527878A1 Antibodies and fusion proteins that include engineered constant regions |
01/27/2005 | CA2525825A1 Hiv polynucleotides and polypeptides derived from botswana mj4 |
01/27/2005 | CA2522508A1 Antisense antiviral agent and method for treating ssrna viral infection |
01/26/2005 | EP1500700A2 Pectic acid lyase |
01/26/2005 | EP1499895A2 Functionalized nanoparticles and methods of use |
01/26/2005 | EP1499637A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same |
01/26/2005 | EP1499627A2 Nuclease resistant chimeric oligonucleotides |
01/26/2005 | EP1499626A2 Solid phase methods for polynucleotide production |
01/26/2005 | EP1499176A2 Novel vip3 toxins and methods of use |
01/26/2005 | EP1152009B1 Novel nucleosides and oligonucleotide analogues |
01/26/2005 | EP1061950B1 Live vaccine for human immunodeficiency virus |
01/26/2005 | EP0960947B1 Methods for judging the possibility of the onset of bovine leukemia and the resistance thereto |
01/26/2005 | EP0769968B1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
01/26/2005 | EP0725826B1 Improvements relating to cancer therapy |
01/26/2005 | CN1570142A Method for genotyping and quantifying hepatitis B virus |
01/26/2005 | CN1570141A Gene positioning method utilizing beeline like nucleic acid chain specimen |
01/26/2005 | CN1570137A Length equivalent double chain specific probe for nucleic acid detection |
01/26/2005 | CN1570136A Human type mycoplasma DNA sequence (3) specificity determination and its uses |
01/26/2005 | CN1570111A Corn height related gene and coding protein and uses |
01/26/2005 | CN1570103A Wheat fertile activity recovery gene RF6 molecular mark and its obtaining method |
01/26/2005 | CN1570102A Wheat yellow dwarf disease candidate resistance gene and its coded protein and uses |
01/26/2005 | CN1570101A Optimized SARS coronary virus N protein gene |
01/26/2005 | CN1570100A Nerval incretion specific protein analog, its coding sequence, making method and uses |
01/26/2005 | CN1569881A CpG-containing single chain deoxy-oligonucleotide having anti-influenza virus |
01/26/2005 | CN1569880A SEA mutant gene and use for fusion protein thereof with ScFv gene |
01/26/2005 | CN1569879A Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
01/26/2005 | CN1569878A siRNA nucleic acid sequence for SARS coronavirus causing gene and its pharmaceutical use |
01/26/2005 | CN1569877A Nucleotide specific for shigella dysenteiae 10 O-antigen |
01/26/2005 | CN1569876A Nucleotide specific for escherichia coli 012 O-antigen |
01/26/2005 | CN1569875A Nucleotide specific for escherichia coli 0149 O-antigen |
01/26/2005 | CN1569874A Nucleotide specific for escherichia coli 0123 O-antigen |
01/26/2005 | CN1569873A Antisense nucleic acid sequence for SARS coronavirus gene and its pharmaceutical use |
01/26/2005 | CN1569872A Antisense nucleic acid for inhibiting SARS virus gene expression and its use |
01/26/2005 | CN1569871A Gene promoter of bacillus pumilus and its polynucleotide sequence |
01/26/2005 | CN1569870A Nucleotide analogs with six-membered rings |
01/26/2005 | CN1186448C Recombinant human alpha-prothymosin interleukin 2 gene and its expression and use |
01/26/2005 | CN1185974C Decoration containing DNA and its preparing process |
01/25/2005 | USRE38689 Ceramidase gene |
01/25/2005 | US6846972 Plant disease resistance genes |
01/25/2005 | US6846922 Activators for oligonucleotide synthesis |
01/25/2005 | US6846629 Methods and apparatus for improved luminescence assays using microparticles |
01/25/2005 | US6846621 Typing of human enteroviruses |
01/25/2005 | CA2155756C Borrelia burgdorferi spirochete specific nucleic acid probes |
01/20/2005 | WO2005005651A2 T cell receptor sequence and method for detecting and treating rheumatoid arthritis |
01/20/2005 | WO2005005610A2 Mutant adeno-associated virus virions and methods of use thereof |
01/20/2005 | WO2005005599A2 Modulation of c-reactive protein expression |
01/20/2005 | WO2005005598A2 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
01/20/2005 | WO2005005450A1 Method of synthesizing cyclic bisdinucleoside |
01/20/2005 | WO2005004814A2 Sirt1 and genetic disorders |
01/20/2005 | WO2005004794A2 Method of treating neurodegenerative disease |
01/20/2005 | WO2004093788A9 Desmoglein 4 is a novel gene involved in hair growth |
01/20/2005 | WO2004079367A8 Bioarray |
01/20/2005 | WO2004070005B1 Double ended sequencing |
01/20/2005 | WO2004048925A3 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
01/20/2005 | WO2004043977A3 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations |
01/20/2005 | WO2004024886A3 Microarray synthesis and assembly of gene-length polynucleotides |
01/20/2005 | WO2004018620A3 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter |
01/20/2005 | WO2003064688A3 Method of generation and management of unique sequences in dna production |
01/20/2005 | US20050015833 Method for delivery of proteins to plant cells |
01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
01/20/2005 | US20050014713 Controlling gene expression;diagnosis, therapy of disease; antidiabetic agents; insulin resistance |
01/20/2005 | US20050014712 Oligomeric compounds for the modulation survivin expression |
01/20/2005 | US20050014710 Compositions and methods relating to prostate specific genes and proteins |